Rigel Pharmaceuticals

Rigel Pharmaceuticals, Inc. (Rigel) is a clinical-stage drug development company. The company discovers and develops small molecule drugs for the treatment of inflammatory/autoimmune diseases as well as certain cancers and metabolic disorders. Its research focuses on intracellular signaling pathways and key related targets in disease mechanisms. The company has product development programs targeting inflammatory/autoimmune diseases (such as rheumatoid arthritis, thrombocytopenia, and asthma) as well as cancer.